Big breakouts for biotechs ?

*Together with

Here are our top 3 investing ideas today. These setups look primed! Be the best prepared trader on the Street!

BBIO – Up over 60% in pre-market after positive Phase 3 results in transthyretin amyloid cardiomyopathy treatment

ABOS – Up over 90% in pre-market after presenting Phase 1 Alzheimer’s results at international conference

GP – Up over 16% in pre after reporting better than expected earnings, revenue up over 255% YoY

*An issuer-paid message from US GoldMining, Inc

US GoldMining, Inc (NASDAQ: USGO)

US GoldMining, Inc (Nasdaq: USGO), is a newly-minted exploration and mine development company focused on unlocking the substantial value of the Whistler gold-copper project, located in Alaska.

USGO just completed an IPO in April 2023, listing on Nasdaq and has raised $20 Million for exploration and mining studies of the Whistler project. All told, we’re looking at a very cut-and-dry situation:

The price of gold has done nothing but go up lately, currently pressing $2000. Projections are for it to surge to $2,200 or more, with some analysts suggesting a rise to even $17,000 per ounce by 2032.

Their CEO, Tim Smith, is a renowned industry veteran with a history of selling gold deposits at prices much higher than average… potentially as much as $1.2 billion in this case if he matches his previous record.

Many people remember seeing the stock jump over 70% after the recent IPO. Right now, it is sitting at a critical technical level.

Do your due diligence, and make sure you keep an eye on USGO today.

*Issuer-paid by US GoldMining, Inc. Please see disclosures below

BBIO – Up over 60% in pre-market after positive Phase 3 results in transthyretin amyloid cardiomyopathy treatment

BridgeBio Pharma (BBIO) engages in the discovery, development and delivery of various medicines for genetic diseases.

This morning the company announced that its phase 3 ATTRibute-CM study of Acoramidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) showed consistently positive results and met its primary endpoint with highly statistically significant results:

– On-treatment survival rate of 81% versus placebo survival rate of 74% (absolute risk reduction of 6.43%; relative risk reduction of 25%)

– Highly statistically significant relative risk reduction of 50% observed on frequency of cardiovascular-related hospitalization

– Highly statistically significant and clinically meaningful treatment benefit observed at 30 months on the secondary endpoints of NT-proBNP, KCCQ and 6-minute walk distance

– No safety signals of potential clinical concern identified

The company also intends to file a new drug application (NDA) with the U.S. Food and Drug Administration by the end of 2023.

The stock was up over 60% in pre-market on the news.

$31 was a resistance level in pre-market and will be an important area to watch.

Above it, the first target for bulls is the pre-market high of $32.73. Beyond that, $34 and $36 come into play, with a gap to fill at $40.62.

Below $31, there is potential support at $29, $27.80, $26.94, $25.40, $22, and a gap to fill at $18.22.

ABOS – Up over 90% in pre-market after presenting Phase 1 Alzheimer’s results at international conference

Acumen Pharmaceuticals (ABOS) a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer’s disease.

Yesterday, ABOS presented positive topline results from first-in-human phase 1 study of acu193 for early Alzheimer’s disease at the Alzheimer’s Association International Conference (AAIC).

The company announced, “Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating proof-of-mechanism for ACU193, the first clinical-stage amyloid beta oligomer (A?O)-targeting antibody.”

The stock is trading 90% higher in pre-market on the news.

The $9.15 area was resistance in the pre-market and now has become an area of potential support.

Above it, the forest major target for bulls is the pre-market high at $9.69. Beyond that, $10, $11 and $13 come into play.

Below $9.15, there is potential support at $8.70, $8.32, $7 and a gap to fill at $6.28.

GP – Up over 16% in pre after reporting better than expected earnings, revenue up over 255% YoY

GreenPower Motor Company (GP) designs, manufactures and distributes electric vehicles for commercial markets in the United States and Canada.

The company reported better than expected earnings this morning with record revenue of $15.3 million for the 4th quarter (vs. $13.98M estimate) and $39.7 million for fiscal year 2023.

The company stated it had delivered 123 vehicles with a majority of the deliveries being EV Star Cab and Chassis, as well as EV Star Cargoes, EV Stars and Nano BEAST Type A school buses.

Q4 revenue represents a 255% year-over-year increase for the company and the stock was up 16% in pre-market on the earnings report.

The $4 level has acted as support and resistance in the pre-market and will be an important pivot level to watch.

Above it, targets to the upside are $4.50, $5 and then the pre-market high of $5.69. Beyond that, $6, $7 and $8 come into play.

Below $4, there is potential support at $3.73 and a gap to fill at $3.48.

*This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results

*PAID ADVERTISEMENT. RagingBull has been paid fifty thousand dollars by ach bank transfer by US GoldMining, Inc for advertising from a period beginning on July 17, 2023 through August 30 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of RagingBull do not hold a position in US GoldMining, Inc. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of US GoldMining, Inc, increased trading volume, and possibly an increased share price of the US GoldMining, Inc securities, which may or may not be temporary and decrease once the marketing arrangement has ended.

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull’s business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www.sec. gov/edgar/searchedgar/companysearch

TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.

Source link

from NYSE Updates – My Blog https://ift.tt/XhtcsGV
via IFTTT